MYELOID LEUKEMIA
Clinical trials for MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to rebuild strength in young cancer survivors
Disease control Recruiting nowThis study tests whether a special exercise program combined with a vitamin-like supplement (called NR) can help teens and young adults who had a bone marrow transplant rebuild lost muscle and improve their fitness. About 80 participants, ages 10 to 30, will be randomly assigned …
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 17, 2026 08:03 UTC
-
New pill shows promise for leukemia patients who failed other therapies
Disease control Recruiting nowThis study tests an experimental pill called HQP1351 in people with chronic myeloid leukemia (CML) or a type of acute lymphoblastic leukemia (Ph+ ALL) that has not responded to at least two prior treatments. The goal is to find the best dose and see how safe and effective the dru…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated May 17, 2026 08:02 UTC
-
New drug combo targets Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests a combination of two drugs, gilteritinib and momelotinib, for adults with a specific type of acute myeloid leukemia (AML) that has come back or not responded to treatment. The main goal is to find the safest dose of momelotinib when given with gilteritinib. About…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for hard-to-treat leukemia: drug combo targets resistant cancer cells
Disease control Recruiting nowThis study tests a new drug combination for adults with acute myeloid leukemia (AML) whose cancer did not respond to or came back after standard treatment. About 30 participants will receive mitoxantrone added to their current therapy to see if it can safely improve outcomes. The…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 14, 2026 12:06 UTC